Ignite Creation Date:
2025-12-26 @ 11:12 PM
Ignite Modification Date:
2026-03-01 @ 12:32 PM
Study NCT ID:
NCT02739412
Status:
COMPLETED
Last Update Posted:
2022-12-19
First Post:
2016-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-05
First Submit QC Date:
None
Study First Post Date:
2016-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-15
Last Update Post Date:
2022-12-19
Last Update Post Date Type:
ACTUAL